ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMP Amphion Innovations Plc

0.15
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Amphion Innovations Plc LSE:AMP London Ordinary Share GB00B0DJNP99 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.15 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Amphion Innovations PLC Appeal Ruling (7056E)

14/04/2014 7:00am

UK Regulatory


Amphion Innovations (LSE:AMP)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Amphion Innovations Charts.

TIDMAMP

RNS Number : 7056E

Amphion Innovations PLC

14 April 2014

Amphion Innovations plc

DataTern Inc., Receives Favourable Appeal Ruling

London and New York, 14 April 2014 - DataTern Inc., a wholly-owned subsidiary of Amphion Innovations plc (AIM: AMP) ("Amphion" or "the Company"), has received a favourable decision on its appeal to the US Court of Appeals for the Federal Circuit. The appeal was a result of the ruling that was rendered in December 2012 by the US District Court for the Southern District of New York in the declaratory judgment actions brought by SAP and Microsoft in April 2011.

As previously announced in Amphion's RNS announcement of 17 April 2013, DataTern's appeal was based on its belief that the New York court lacked jurisdiction and that the Markman claim construction rendered on DataTern's patents was flawed.

The Federal Circuit's decision broadly found in favour of DataTern's position.

Richard Morgan, CEO of Amphion, said; "This is a good result. This ruling will allow us to continue to try to reach equitable licensing agreements with the many companies that are infringing these patents. Our goal remains to generate a fair and reasonable return on the very substantial investment we have made over many years in the development of these innovative technologies."

For further information please contact:

Amphion Innovations

Charlie Morgan

+1 212 210 6224

Novella Communications

Tim Robertson / Ben Heath

+44 020 3151 7008

Panmure Gordon Limited

Freddy Crossley / Fred Walsh / (Corporate Finance)

Adam Pollock / Charlie Leigh-Pemberton (Corporate Broking)

+44 020 7886 2500

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: www.amphionplc.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCQKBDBCBKKDQD

1 Year Amphion Innovations Chart

1 Year Amphion Innovations Chart

1 Month Amphion Innovations Chart

1 Month Amphion Innovations Chart

Your Recent History

Delayed Upgrade Clock